$9.3 Billion Liquid Biopsy Market 2021: Global Trends, Forecast and Competitive Analysis Report 2015-2026 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Liquid Biopsy Market Report: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering.

The global liquid biopsy market is expected to reach an estimated $9.3 billion by 2026 with a CAGR of 17% from 2020 to 2026.

The future of the global liquid biopsy market looks promising with opportunities in reference laboratories, hospitals and physician laboratories, and academic and research centers. The major drivers for this market are the increasing prevalence of cancer, preference for non-invasive procedures and increasing need of early detection of high precision diseases in real time.

Emerging trends, which have a direct impact on the dynamics of the industry, include the usage of methylation-specific polymerase chain reaction (MS-PCR) liquid biopsy technology and the emergence of hybrid ctDNA and CTC target selector.

Some of the liquid biopsy companies profiled in this report Guardant, Bio-Rad Laboratories, Qaigen, MDxHealth, Myraid, Biocept, Roche, Illumina, and Thermofisher.

The analyst circulating tumor DNA will remain the largest segment and is also expected to witness the highest growth over the forecast period due to increasing use of ctDNA biomarkers in next-generation sequencing (NGS) technologies for detecting disease in real time and in early stage.

Therapy selection will remain the largest clinical application over the forecast period due to its offerings of various benefits such as non-invasiveness, access to tumor heterogeneity, real-time treatment monitoring, and recurrence detection in advance of significant tumor formation or metastasis.

APAC will remain the fastest growing region over the forecast period due to rising non-invasive treatment, a rising incidence of cancer, and improving healthcare infrastructure.

Features of the Global Liquid Biopsy Market

• Market Size Estimates: Global liquid biopsy market size estimation in terms of value ($B) and volume (Million Metric Ton) shipment.
• Trend and Forecast Analysis: Market trends (2015-2020) and forecast (2021-2026) by various segments.
• Segmentation Analysis: Global liquid biopsy market size by product, circulating biomarker, application, clinical application, end user, and region in terms of value.
• Regional Analysis: Global liquid biopsy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different by product, circulating biomarker, application, clinical application, end user, and region for the global liquid biopsy market.
• Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the global Liquid Biopsy market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

The study includes trends and forecasts for the global liquid biopsy market by product, circulating biomarker, application, clinical application, end user, and region as follows:

By Product [Value ($M) from 2015 to 2026]:

• Assays Kits
• Instruments
• Services

By Circulating Biomarker [Value ($M) from 2015 to 2026]:

• Circulating Tumor Cells (CTCs)
• Circulating Tumor DNA (CtDNA)
• Cell-Free DNA (cfDNA)
• Extracellular Vesicles (EVs)
• Other Biomarkers

By Application [Value ($ Million) from 2015 to 2026]:

• Oncology
• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Prostate Cancer
• Liver Cancer
• Other Cancers
• Non-Cancer

By Clinical Application [Value ($ Million) from 2015 to 2026]:

• Early Cancer Screening
• Therapy Selection
• Treatment Monitoring
• Recurrence Monitoring

By End User [Value ($ Million) from 2015 to 2026]:

• Reference Laboratories
• Hospitals and Physician Laboratories
• Academic and Research Centers
• Other End Users

By Region [Value ($ Million) from 2015 to 2026]:

• North America
• US
• Canada
• Mexico
• Europe
• United Kingdom
• France
• Germany
• Italy
• Spain
• APAC
• China
• Japan
• India
• ROW
• Brazil

Companies Mentioned

• Bio-Rad Laboratories
• QIAGEN
• MDxHealth
• Myriad Genetics
• Biocept, Inc.
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• Cardiff Oncology
• Guardant Health

For more information about this report visit https://www.researchandmarkets.com/r/ogbvvq